Herrmann E K, Hahn K, Kratzer C, von Seggern I, Zimmer C, Schielke E
Department of Neurology, Charité, University Medicine Berlin, Campus Mitte, D-13125 Berlin, Germany.
AJNR Am J Neuroradiol. 2006 Jun-Jul;27(6):1245-51.
Cerebral atrophy following herpes simplex encephalitis has formerly been described. We aimed to quantify atrophy after encephalitis of various causes. Additional objectives were to define which initial or long-term clinical factors correlate with volume loss and to search for any correlate in global clinical outcome measures.
MR imaging was performed in 40 subjects in the acute stage of encephalitis and > or =6 months after onset of symptoms. The ventricle brain ratio (VBR) was measured on corresponding images from disease onset and follow-up, and the change in VBR (VBR delta) was calculated as a percentage value of the starting measure. Clinical outcome was evaluated by interview and neurologic examination and characterized by using an encephalitis-adapted version of the modified Rankin Scale.
The VBR delta ranged from -5%-102% (median, 5.93%; lower quartile, 1.8%; upper quartile, 14.55%; mean, 14.43%; SD, 23.75%). We found significant differences in the VBR delta between those patients who required intensive care (P = .027), had more than 2 epileptic seizures or a status epilepticus during the acute stage (P = 0.021), or developed postencephalitic epilepsy (P = .015) and their respective counter-subgroups. Three patients were rated to have unfavorable outcome (modified Rankin Scale, 3-5). Patients with unfavorable clinical outcomes tended to show greater VBR delta values, but a statistical evaluation was impossible because of small numbers.
More than 2 epileptic seizures or a status epilepticus during the acute stage of encephalitis is associated with a greater loss of parenchyma.
既往已有关于单纯疱疹病毒性脑炎后脑萎缩的描述。我们旨在对各种病因所致脑炎后的萎缩情况进行量化。其他目标包括确定哪些初始或长期临床因素与体积丢失相关,并在整体临床结局指标中寻找任何相关性。
对40例处于脑炎急性期以及症状发作后≥6个月的受试者进行磁共振成像检查。在疾病发作时及随访的相应图像上测量脑室脑比率(VBR),并将VBR的变化(VBRδ)计算为起始测量值的百分比。通过访谈和神经学检查评估临床结局,并使用改良Rankin量表的脑炎适用版本进行特征描述。
VBRδ范围为-5%至102%(中位数为5.93%;下四分位数为1.8%;上四分位数为14.55%;均值为14.43%;标准差为23.75%)。我们发现,需要重症监护的患者(P = 0.027)、在急性期有超过2次癫痫发作或癫痫持续状态的患者(P = 0.021)或发生脑炎后癫痫的患者(P = 0.015)与各自的对照组相比,VBRδ存在显著差异。3例患者被评定为预后不良(改良Rankin量表评分为3 - 5分)。临床结局不良的患者往往显示出更大的VBRδ值,但由于数量较少,无法进行统计学评估。
脑炎急性期超过2次癫痫发作或癫痫持续状态与实质组织的更大丢失相关。